Sangamo Biosciences Financial Overview
Sangamo Biosciences's market cap is currently $143.01M. The company's EPS TTM is $-0.11; its P/E ratio is -0.96; Sangamo Biosciences is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.
